CA1113478A - Oxepanes - Google Patents

Oxepanes

Info

Publication number
CA1113478A
CA1113478A CA291,123A CA291123A CA1113478A CA 1113478 A CA1113478 A CA 1113478A CA 291123 A CA291123 A CA 291123A CA 1113478 A CA1113478 A CA 1113478A
Authority
CA
Canada
Prior art keywords
methyl
dimethyl
nonenyl
oxo
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA291,123A
Other languages
English (en)
French (fr)
Inventor
Ramesh M. Kanojia
Michael P. Wachter
Robert H.K. Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Application granted granted Critical
Publication of CA1113478A publication Critical patent/CA1113478A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/04Seven-membered rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA291,123A 1976-11-18 1977-11-17 Oxepanes Expired CA1113478A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US742,940 1976-11-18
US05/742,940 US4102895A (en) 1976-11-18 1976-11-18 Oxepanes

Publications (1)

Publication Number Publication Date
CA1113478A true CA1113478A (en) 1981-12-01

Family

ID=24986860

Family Applications (1)

Application Number Title Priority Date Filing Date
CA291,123A Expired CA1113478A (en) 1976-11-18 1977-11-17 Oxepanes

Country Status (15)

Country Link
US (1) US4102895A (ref)
JP (1) JPS5365890A (ref)
AT (1) AT363478B (ref)
AU (1) AU516476B2 (ref)
CA (1) CA1113478A (ref)
CH (3) CH627469A5 (ref)
DE (1) DE2751396A1 (ref)
FR (1) FR2371443A1 (ref)
GB (1) GB1594100A (ref)
GR (1) GR63241B (ref)
IE (1) IE45915B1 (ref)
IL (1) IL53420A (ref)
NZ (1) NZ185641A (ref)
PH (1) PH13596A (ref)
ZA (1) ZA776879B (ref)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182717A (en) * 1978-06-29 1980-01-08 Ortho Pharmaceutical Corp. Total synthesis of the utero-evacuant substance d,l-zoapatanol
US4177194A (en) * 1978-06-29 1979-12-04 Ortho Pharmaceutical Corporation Total synthesis of the utero-evacuant substance D,L-zoapatanol
US4256644A (en) * 1978-12-18 1981-03-17 Ortho Pharmaceutical Corporation Chemical intermediates in the preparation of oxepane compounds
US4215048A (en) * 1979-05-18 1980-07-29 Ortho Pharmaceutical Corporation Total synthesis of (1RS, 4SR, 5RS)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4237054A (en) * 1979-05-18 1980-12-02 Ortho Pharmaceutical Corporation Total synthesis of (1RS,4SR,5RS)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1] octane-1-acetic acid
US4237055A (en) * 1979-06-18 1980-12-02 Ortho Pharmaceutical Corporation Synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4322353A (en) * 1980-04-18 1982-03-30 Ortho Pharmaceutical Corporation Synthesis of dioxabicyclo(3.2.1)octanes and oxepanes
US4284565A (en) * 1980-05-02 1981-08-18 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl)-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid and related compounds
US4329288A (en) * 1980-05-02 1982-05-11 Ortho Pharmaceutical Corporation (1RS,4SR,5RS)-4-(5-Hydroxy-4,8-dimethyl-8-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
KR850000218B1 (ko) * 1980-07-31 1985-03-06 오오소오 화아마슈이티갈 코오포레이숀 디옥사비시클로[3.2.1]옥탄 유도체의 합성방법
US4277401A (en) * 1980-08-25 1981-07-07 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl)-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4307019A (en) * 1980-08-25 1981-12-22 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS,-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4322357A (en) * 1981-02-23 1982-03-30 Ortho Pharmaceutical Corporation Novel cycloheptanes
US4360467A (en) * 1981-02-23 1982-11-23 Ortho Pharmaceutical Corporation Process for preparing 8-oxabicyclo[3.2.1]-octane-1-acetic acids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515670C2 (de) * 1975-04-10 1985-07-25 Ortho Pharmaceutical Corp., Raritan, N.J. Verfahren zum Isolieren von Substanzen mit uteroevakuierender Wirkung aus der Zoapatl-Pflanze und diese Substanzen enthaltende Arzneimittel

Also Published As

Publication number Publication date
US4102895A (en) 1978-07-25
DE2751396A1 (de) 1978-05-24
IE45915L (en) 1978-05-18
CH627469A5 (fr) 1982-01-15
FR2371443A1 (fr) 1978-06-16
CH629792A5 (fr) 1982-05-14
NZ185641A (en) 1984-08-24
JPS5365890A (en) 1978-06-12
JPS625154B2 (ref) 1987-02-03
ATA824077A (de) 1981-01-15
AU3072977A (en) 1979-05-24
AU516476B2 (en) 1981-06-04
CH629793A5 (fr) 1982-05-14
GB1594100A (en) 1981-07-30
ZA776879B (en) 1979-06-27
FR2371443B1 (ref) 1984-02-24
AT363478B (de) 1981-08-10
GR63241B (en) 1979-10-12
IE45915B1 (en) 1982-12-29
IL53420A0 (en) 1978-01-31
PH13596A (en) 1980-08-05
IL53420A (en) 1983-05-15

Similar Documents

Publication Publication Date Title
CA1113478A (en) Oxepanes
Dhawan et al. Calixarenes. 10. oxacalixarenes
Kajimoto et al. Sesquiterpenoid and disulphide derivatives from Ferula assa-foetida
CH647222A5 (de) 9-desoxy-9a-methylen-isostere von pgi-2 und verfahren zu deren herstellung.
CH636096A5 (de) Bicyclische prostaglandine, verfahren zu ihrer herstellung und pharmazeutische praeparate.
Kotsuki et al. High pressure organic chemistry. 2. Diels-Alder reaction of thiophene with maleic anhydride at very high pressure
DE2622123A1 (de) Prostaglandin-analoge
Ku et al. Synthesis and LTD4 antagonist activity of 2-norleukotriene analogs
Pettit et al. Antineoplastic agents. 34. Helenium autumnale
Kuwahara et al. Synthesis and absolute configuration of syringolide 2, an elicitor from Pseudomonas syringae pv. tomato
CH627428A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit primaerer alkoholgruppe am c-1.
Kimura et al. Isolation and structure of pestalotin, a gibberellin synergist from Pestalotia cryptomeriaecola
Nakajima et al. Insect development inhibitors from Coleopsis lanceolata L.
Demole et al. A Chemical Study of Burley Tobacco Flavour (Nicotiana tabacuml.) V. Identification and Synthesis of the Novel Terpenoid Alkaloids 1, 3, 6, 6‐Tetramethyl‐5, 6, 7, 8‐tetrahydro‐isoquinolin‐8‐one and 3, 6, 6‐Trimethyl‐5, 6‐dihydro‐7H‐2‐pyrindin‐7‐one
JPH075595B2 (ja) 9―(1,3―ジヒドロキシ―2―プロポキシメチル)グアニン類化合物の製法
DE2502919C2 (de) Cyclopentan-Derivate, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
US4868204A (en) Mycalamide compounds, compositions thereof and methods of preparation and use
Sasaki et al. The alkaloids of Anodendron affine Druce
Young et al. Synthesis of octahydrothiopyrano [3, 2-b] thiopyran and certain derivatives
US4103091A (en) Method for the preparation of prostaglandin intermediates from a mold metabolite
JPS6377828A (ja) イソプレン誘導体
Rosenberger et al. Steroid Total Synthesis, Part VII;(±)‐estr‐4‐ene‐3, 17‐dione and (±) 13β‐ethyl‐gon‐4‐ene‐3, 17‐dione
AU634286B2 (en) Additional further novel alkanophenones
Brown et al. Studies related to the total synthesis of alkaloids in the carpaine and cassine series. Part 6. Total synthesis of (±)-azimic acid
Sedmera et al. AUTUMNALE L.~'

Legal Events

Date Code Title Description
MKEX Expiry